Table 3.
All patients n = 288 | < 25 n = 87 | 25−30 n = 110 | > 30 n = 91 | p value | |
---|---|---|---|---|---|
Adverse event | 100 (34.8) | 34 (39.1) | 30 (27.5) | 36 (39.6) | 0.126 |
Stroke | 10 (4.2) | 3 (4.4) | 3 (3.2) | 4 (5.3) | 0.797 |
Thromboembolic event | 6 (2.5) | 1 (1.4) | 4 (4.3) | 1 (1.4) | 0.385 |
Recurrence of troponin‐positive with nonobstructive CAD | 3 (1.3) | 1 (1.4) | 1 (1.1) | 1 (1.4) | 0.981 |
Percutaneous coronary intervention | 17 (7.2) | 7 (10) | 4 (4.3) | 6 (8.2) | 0.352 |
Death | 69 (24.1) | 26 (29.9) | 18 (16.7) | 25 (27.5) | 0.067 |
‐ Cardiac caused death | 5 (2.1) | 4 (5.7) | 1 (1.1) | 0 (0) | 0.042 |
‐ Noncardiac caused death | 12 (5.1) | 5 (7.1) | 1 (1.1) | 6 (8.3) | 0.075 |
Abbreviations: Adverse event, major adverse cardiac and cerebrovascular events; CAD, coronary artery disease; CPR, cardiopulmonary resuscitation; NSTEMI, non‐ST‐segment elevation myocardial infarction; STEMI, ST‐segment elevation myocardial infarction.